EXEL

Exelixis, Inc. Common Stock

$27.63 +$0.05 +0.18%


Own 2 of EXEL at $26.90

Shares Bought3
Shares Sold1
Total4
Shares Owned2
Last Price$27.63
Total Return$2.87
Range Today$27.51 - $27.78
52 Week Range$10.04 - $29.50
Open$27.53
Market Cap$8.10B
Volume/Average509.81K/4.97M
P/E Ratio145.42
Dividend/Yield-




Exelixis, Inc. is a biopharmaceutical company. It engages in the developing and commercializing small molecule therapies for the treatment of cancer. The company brands include comertriq and cobimetinib. Its pipeline consists of cabozantinib, cobimetinib and Xl 888. Exelixis was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in South San Francisco, CA.


Orders

Date Side Shares Price
08-16-2017 15:14:13 buy 1 $26.89
08-16-2017 15:15:44 buy 1 $26.86
08-16-2017 15:25:18 buy 1 $26.95
08-30-2017 21:58:02 sell 1 $28.30